000 | 01651 a2200445 4500 | ||
---|---|---|---|
005 | 20250513144852.0 | ||
264 | 0 | _c19980709 | |
008 | 199807s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBadger, A M | |
245 | 0 | 0 |
_aSB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJul 1998 |
||
300 |
_a467-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aCartilage, Articular _xdrug effects |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aChondrocytes _xdrug effects |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
650 | 0 | 4 | _aMitogen-Activated Protein Kinases |
650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
700 | 1 | _aCook, M N | |
700 | 1 | _aLark, M W | |
700 | 1 | _aNewman-Tarr, T M | |
700 | 1 | _aSwift, B A | |
700 | 1 | _aNelson, A H | |
700 | 1 | _aBarone, F C | |
700 | 1 | _aKumar, S | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 161 _gno. 1 _gp. 467-73 |
|
999 |
_c9613401 _d9613401 |